A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 35,800 shares of ARCT stock, worth $578,886. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,800
Previous 43,200 17.13%
Holding current value
$578,886
Previous $1.05 Million 21.03%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$18.08 - $25.38 $980,333 - $1.38 Million
54,222 Added 250.66%
75,854 $1.76 Million
Q2 2024

Aug 14, 2024

SELL
$24.35 - $44.39 $3.54 Million - $6.46 Million
-145,462 Reduced 87.05%
21,632 $526,000
Q1 2024

May 15, 2024

BUY
$31.23 - $42.99 $5.21 Million - $7.17 Million
166,727 Added 45429.7%
167,094 $5.64 Million
Q4 2023

Feb 14, 2024

SELL
$17.71 - $32.97 $2.61 Million - $4.86 Million
-147,506 Reduced 99.75%
367 $11,000
Q3 2023

Nov 14, 2023

BUY
$25.44 - $37.35 $660,473 - $969,680
25,962 Added 21.3%
147,873 $3.78 Million
Q2 2023

Aug 14, 2023

SELL
$23.94 - $32.36 $4.62 Million - $6.24 Million
-192,878 Reduced 61.27%
121,911 $3.5 Million
Q1 2023

May 15, 2023

BUY
$14.72 - $23.97 $169,029 - $275,247
11,483 Added 3.79%
314,789 $7.55 Million
Q4 2022

Feb 14, 2023

BUY
$14.14 - $23.06 $1.6 Million - $2.6 Million
112,903 Added 59.3%
303,306 $5.14 Million
Q3 2022

Nov 14, 2022

BUY
$13.05 - $22.13 $1.66 Million - $2.81 Million
126,867 Added 199.68%
190,403 $2.82 Million
Q2 2022

Aug 15, 2022

SELL
$12.26 - $31.17 $418,029 - $1.06 Million
-34,097 Reduced 34.92%
63,536 $1 Million
Q1 2022

May 16, 2022

BUY
$17.64 - $39.57 $1.45 Million - $3.26 Million
82,316 Added 537.42%
97,633 $2.63 Million
Q4 2021

Feb 14, 2022

SELL
$34.2 - $47.56 $1.93 Million - $2.68 Million
-56,420 Reduced 78.65%
15,317 $566,000
Q3 2021

Nov 15, 2021

SELL
$27.88 - $58.25 $3.31 Million - $6.92 Million
-118,884 Reduced 62.37%
71,737 $3.43 Million
Q1 2021

May 17, 2021

BUY
$38.75 - $86.92 $5.9 Million - $13.2 Million
152,371 Added 398.36%
190,621 $7.87 Million
Q4 2020

Feb 16, 2021

SELL
$34.61 - $123.66 $9.41 Million - $33.6 Million
-271,999 Reduced 87.67%
38,250 $1.66 Million
Q3 2020

Nov 16, 2020

SELL
$37.49 - $63.19 $14.5 Million - $24.5 Million
-388,035 Reduced 55.57%
310,249 $13.3 Million
Q2 2020

Aug 14, 2020

BUY
$12.66 - $58.27 $8.65 Million - $39.8 Million
683,546 Added 4637.98%
698,284 $32.6 Million
Q1 2020

May 15, 2020

BUY
$9.31 - $18.26 $16,804 - $32,959
1,805 Added 13.96%
14,738 $200,000
Q4 2019

Feb 14, 2020

BUY
$8.93 - $12.41 $115,491 - $160,498
12,933 New
12,933 $141,000

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $430M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.